Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual.
about
APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancerSentinel Lymph Node in Breast Cancer: Review Article from a Pathologist's Point of ViewCorrelation of immunoglobulin G expression and histological subtype and stage in breast cancerNuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer.Relationship between parameters from virtual touch tissue quantification (VTQ) imaging with clinicopathologic prognostic factors in women with invasive ductal breast cancerNuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinomaA genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancerRole of tumor size in the pre-operative management of rectal cancer patients.Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake.Myeloid cells in circulation and tumor microenvironment of breast cancer patientsAlpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells.Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients.Breast cancer cell adhesome and degradome interact to drive metastasisAn improved axillary staging system using the OSNA assay does not modify the therapeutic management of breast cancer patients.Histologic evaluation of sentinel and non-sentinel axillary lymph nodes in breast cancer by multilevel sectioning and predictors of non-sentinel metastasis.Serum tryptase, mast cells positive to tryptase and microvascular density evaluation in early breast cancer patients: possible translational significance.MR and optical imaging of early micrometastases in lymph nodes: triple labeling with nano-sized agents yielding distinct signals.miRNA as potential biomarkers of breast cancer in the Lebanese population and in young women: a pilot study.Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients' heart?Iron-binding proteins and C-reactive protein in Nipple Aspirate Fluids: role of Iron-driven inflammation in breast cancer microenvironment?Exploring molecular links between lymph node invasion and cancer prognosis in human breast cancer.Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.Axillary staging in breast cancer patients with exclusive lymphoscintigraphic drainage to the internal mammary chain.The effects of applying breast compression in dynamic contrast material-enhanced MR imagingEvaluation of prognostic factors in stage IIA breast tumors and their correlation with mortality riskEffect of genetic variants in two chemokine decoy receptor genes, DARC and CCBP2, on metastatic potential of breast cancerPrimary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival.Luminal B subtype: a key factor for the worse prognosis of young breast cancer patients in China.Thrombin-activatable fibrinolysis inhibitor Thr325Ile polymorphism and plasma level in breast cancer: A pilot study.Staging of breast cancer in the neoadjuvant setting.FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis.Online tool to guide decisions for BRCA1/2 mutation carriers.The Clinical Significance and Molecular Features of the Spatial Tumor Shapes in Breast CancersTechnical limits of comparison of step-sectioning,immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacarn-fixed tissue.A single institution experience with skin sparing mastectomy and immediate breast reconstruction.The Glycolytic Phenotype is Correlated with Aggressiveness and Poor Prognosis in Invasive Ductal Carcinomas.Benefit of semiannual ipsilateral mammographic surveillance following breast conservation therapyBreast-conserving therapy and modified radical mastectomy for primary breast carcinoma: a matched comparative study.Axillary ultrasound and fine-needle aspiration in preoperative staging of axillary lymph nodes in patients with invasive breast cancer.
P2860
Q24304176-AECBEE1D-DB02-48EE-816C-1468BB2DA8EBQ26772240-832289F2-6C0A-40D0-81E2-6E8E876B3BC4Q28703880-359EB9F9-35D4-4C7A-846A-C21A0BECBCEBQ30156863-37E1A849-BF8E-471F-A7A5-543E72EEF2AEQ30426167-57EAF582-B7E0-418D-A461-7B8708EB5ED8Q33303620-0D677FEC-83B1-45DC-BD93-A0E929AD4F01Q33584346-AF75A2BF-FF4B-4508-9BEF-5EFC64BFB8F8Q33605399-27A1382A-C4C9-40BB-86A3-521BE9E91B00Q33649722-EC222C2A-60FD-4B01-BCB8-6C8254E0FF60Q33729434-33DB99B6-2412-443D-886F-521D222CA2FAQ33765134-67EABC42-6F75-470A-8EB0-E1543AA22E44Q33836906-624B50AA-9B70-4A9F-A6CC-4F1B97FC7775Q33914711-C669B079-A37B-42FA-BAFE-15DA6D61FEF1Q33917902-9E4FF5FE-4B77-4AE6-B6C2-6561FC6F3F70Q33973186-AB0991DC-10C8-4040-B673-0B0671AF9DF3Q33984560-4007EC57-0CD1-41CA-A944-EA7A2AF308E1Q34204259-FDA2A46D-8B02-4497-BC84-ED7639FDF52FQ34215056-69384F3A-F000-4F93-A598-7D70B82AD824Q34245323-556795C0-FF72-4A99-8372-13C9D90FEBBEQ34306535-DE525590-526A-469E-BF7E-7A77222CC534Q34310274-DA42C21A-934C-4424-BAF4-00D0519D5BE3Q34333453-285BB9C8-2DED-4938-924A-AA48088D221FQ34366636-32BFEF49-39ED-425E-BD70-88B30F77FFF8Q34427644-08A7B33C-03A3-45E9-9EF1-692507E3627DQ34681250-2B202562-7B51-4936-A8D4-73ED2C40A1F0Q34978755-96DC279E-1B0B-4A91-A7DF-155BE6C768F4Q35048124-F94EA1D6-4737-4044-9B39-5D83B2539B62Q35158995-D2608E41-851F-4E3B-B150-1888A2796A04Q35319271-357FB353-BCE3-4B1F-9B00-E6F6628AB67AQ35436643-0DC95E5A-4A57-41CA-B4DD-A5E4EAF925D3Q35638695-56720071-9B9A-4059-ADFC-5511055435BAQ35794378-C4D96DFC-EC36-48E6-9EA2-F6A4D219E444Q35808372-8D40B1D0-FC27-4BD1-9D1F-E3A1B2567F6FQ35869105-5CBC878E-F67E-47F8-AB84-D3430F176DDAQ35893476-D9D0E9D5-9048-4DE2-967E-A30BD90080F9Q36002094-C0CB6421-09DF-4669-8789-94F48CB23B63Q36092014-63C35A55-93A4-4A0B-B1EC-9250598D2D2AQ36106659-7287B4D9-3D23-457F-B5E4-73BCB59C1590Q36419117-0201BA17-BF46-454F-BBCC-1F6B2B3460D3Q36497911-9EB0478C-18E6-4400-84D3-ECC072FA362B
P2860
Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual.
@ast
Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual.
@en
type
label
Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual.
@ast
Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual.
@en
prefLabel
Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual.
@ast
Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual.
@en
P356
P1433
P1476
Breast cancer staging: working with the sixth edition of the AJCC Cancer Staging Manual.
@en
P2093
James L Connolly
S Eva Singletary
P304
37-47; quiz 50-1
P356
10.3322/CANJCLIN.56.1.37
P407
P577
2006-01-01T00:00:00Z